• 1
    Hartge P, et al. Non-Hodgkin lymphoma. In: SchottenfeldD,FraumeniJFJr, eds. Cancer epidemiology and prevention. Oxford, United Kingdom: Oxford University Press, 2006: 898918.
  • 2
    Sorensen IK, et al. Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice. Carcinogenesis 1996; 17: 22212227.
  • 3
    National Toxicology program. Bioassay of 2,4-diaminotoluene for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser 1979; 162: 1139.
  • 4
    Esumi H, et al. Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res 1989; 80: 11761178.
  • 5
    Ochiai M et al. Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res 2002; 93: 478483.
  • 6
    Morton LM, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: A pooled analysis. Lancet Oncol 2005; 6: 469476.
  • 7
    Nieters A, et al. Tobacco and alcohol consumption and risk of lymphoma: Results of a population-based case-control study in Germany. Int J Cancer 2006; 118: 422430.
  • 8
    Lim U, et al. Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007; 166: 697708.
  • 9
    Monnereau A, et al. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: Results of a French case-control study. Cancer Causes Control 2008; 19: 11471160.
  • 10
    Besson H, et al. Tobacco smoking, alcohol drinking and non-Hodgkin's lymphoma: A European multicenter case-control study (Epilymph). Int J Cancer 2006; 119: 901908.
  • 11
    Morton LM, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: A pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005; 14: 925933.
  • 12
    Chiu BC, et al. Diet and risk of non-Hodgkin lymphoma in older women. JAMA 1996; 275: 13151321.
  • 13
    De Stefani E, et al. Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: A case-control study in Uruguay. Leuk Res 1998; 22: 445452.
  • 14
    Purdue MP, et al. Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: A case-control analysis. Cancer Epidemiol Biomarkers Prev 2004; 13: 16651676.
  • 15
    Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 2003; 17: 2741.
  • 16
    Crofts F, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994; 15: 29612963.
  • 17
    Nebert DW, et al. NAD(P)H: Quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review. Genet Med 2002; 4: 6270.
  • 18
    Pemble S, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300 (Part 1): 271276.
  • 19
    Hu X, et al. Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 1997; 238: 397402.
  • 20
    Ali-Osman F, et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272: 1000410012.
  • 21
    Zimniak P, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994; 224: 893899.
  • 22
    De Roos AJ, et al. Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 16471653.
  • 23
    Soucek P, et al. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Int Arch Occup Environ Health, 2002; 75 ( Suppl): S86S92.
  • 24
    Sarmanova J, et al. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 2001; 10: 12651273.
  • 25
    Kilfoy BA, et al. Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma. Am J Hematol 2009; 279282.
  • 26
    Al-Dayel F, et al. Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population. Leuk Lymphoma 2008; 49: 122129.
  • 27
    Kerridge I, et al. Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 2002; 118: 477481.
  • 28
    Jaffe ES, et al. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press: IARC Press; 2001.
  • 29
    Kim HN, et al. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 2008; 140: 287294.
  • 30
    Ashton LJ, et al. Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma. Pharmacogenet Genomics 2007; 17: 709717.
  • 31
    Chiu BC, et al. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: A population-based case-control study. Br J Haematol 2005; 128: 610615.
  • 32
    Sundberg K, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998; 19: 433436.
  • 33
    Mao GE, et al. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 2004; 28: 368374.
  • 34
    Koutros S, et al. Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res 2009; 69: 18771884.
  • 35
    Shin A, et al. Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 320329.
  • 36
    Butler LM, et al. Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat Res 2008; 638: 162174.
  • 37
    Suzuki H, et al. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis 2008; 29: 11841191.